P1389: RUXOLITINIB DEMONSTRATES A GREATER CORTICOSTEROID-SPARING EFFECT THAN BEST AVAILABLE THERAPY IN PATIENTS WITH CORTICOSTEROID-REFRACTORY/DEPENDENT CHRONIC GRAFT-VS-HOST DISEASE

oleh: R. Zeiser, D. Russo, R. Ram, S. Hashmi, R. Chakraverty, J. Moritz Middeke, S. Giebel, R. Sarkar, M. Gowda, S. Gunes, T. Stefanelli, S. J. Lee, T. Teshima, F. Locatelli